10x Genomics PE Ratio 2018-2025 | TXG

Current and historical p/e ratio for 10x Genomics (TXG) from 2018 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. 10x Genomics PE ratio as of May 30, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

10x Genomics PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-05-30 9.53 0.00
2025-03-31 8.73 $-1.30 0.00
2024-12-31 14.36 $-1.52 0.00
2024-09-30 22.58 $-1.53 0.00
2024-06-30 19.45 $-2.02 0.00
2024-03-31 37.53 $-2.23 0.00
2023-12-31 55.96 $-2.17 0.00
2023-09-30 41.25 $-1.91 0.00
2023-06-30 55.84 $-1.49 0.00
2023-03-31 55.79 $-1.53 0.00
2022-12-31 36.44 $-1.47 0.00
2022-09-30 28.48 $-1.48 0.00
2022-06-30 45.25 $-1.26 0.00
2022-03-31 76.07 $-0.79 0.00
2021-12-31 148.96 $-0.52 0.00
2021-09-30 145.58 $-4.23 0.00
2021-06-30 195.82 $-4.73 0.00
2021-03-31 181.00 $-5.04 0.00
2020-12-31 141.60 $-5.15 0.00
2020-09-30 124.68 $-1.35 0.00
2020-06-30 89.31 $-1.03 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.173B $0.611B
10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $45.506B 58.15
Hims & Hers Health (HIMS) United States $12.660B 131.53
Tempus AI (TEM) United States $9.553B 0.00
IRhythm Technologies (IRTC) United States $4.485B 0.00
Inspire Medical Systems (INSP) United States $4.076B 63.69
Privia Health (PRVA) United States $2.775B 189.67
Enovis (ENOV) United States $1.788B 9.97
Clover Health Investments (CLOV) United States $1.598B 0.00
Schrodinger (SDGR) United States $1.586B 0.00
Phreesia (PHR) United States $1.457B 0.00
Omnicell (OMCL) United States $1.423B 25.10
Azenta (AZTA) United States $1.223B 56.85
Claritev (CTEV) United States $0.632B 0.00
Fulgent Genetics (FLGT) United States $0.631B 0.00
Butterfly Network (BFLY) United States $0.593B 0.00
Talkspace (TALK) United States $0.534B 159.50
Veradigm (MDRX) United States $0.466B 0.00
Standard BioTools (LAB) United States $0.384B 0.00
TruBridge (TBRG) United States $0.360B 797.67
Outset Medical (OM) United States $0.311B 0.00
Health Catalyst (HCAT) United States $0.264B 0.00
Nyxoah SA (NYXH) Belgium $0.261B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.200B 0.00
Pulmonx (LUNG) United States $0.137B 0.00
EUDA Health Holdings (EUDA) Singapore $0.136B 0.00
KORU Medical Systems (KRMD) United States $0.125B 0.00
American Well (AMWL) United States $0.105B 0.00
MDxHealth SA (MDXH) Belgium $0.100B 0.00
CareCloud (CCLD) United States $0.085B 3.26
111 (YI) China $0.071B 0.00
HeartBeam (BEAT) United States $0.057B 0.00
P3 Health Partners (PIII) United States $0.053B 0.00
Zepp Health (ZEPP) Netherlands $0.037B 0.00
Zhongchao (ZCMD) China $0.029B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
Precipio (PRPO) United States $0.014B 0.00
MSP Recovery (MSPR) United States $0.010B 0.00
Strata Skin Sciences (SSKN) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Movano (MOVE) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.003B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00